Close Menu

NEW YORK (GenomeWeb) – Miragen Therapeutics, a clinical-stage biopharmaceutical company focused on the discovery and development of microRNA-targeted therapies, has completed its merger with molecular diagnostics company Signal Genetics. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.